Approval · Notice of Compliance 5446 · 1994
RELAFEN: Notice of Compliance 5446
Issued March 18, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5446
- Date
- March 18, 1994
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Nonsteroidal anti-inflammatory agent
Products in this notice
Medicinal ingredients
- NABUMETONE 500 MG per TAB
- NABUMETONE 750 MG per TAB